Owlet
Owlet360 will provide caregivers personalized insights into their infant's health, sleep patterns and development using the company's pediatric health data.
The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.
The baby-focused technology company is expanding access to its Dream Sock to parents in Poland, Greece, the Czech Republic and other European countries.
The company's Dream Sock, which received FDA 510(k) clearance in November, gathers real-time health readings, including a baby's sleep trends and pulse rate.
Wheel's BabySat virtual telehealth services platform will enable caregivers to obtain a prescription for the baby tech company's pulse oximetry sock.
The company's revenue increased in Q2 of this year to $13.1 million compared to $10.7 million in the first quarter – still below the $18.3 million reported in Q2 2022.
The company will proceed with a 1-for-14 reverse stock split of its Class A common stock effective July 7.
BabySat, available via prescription, alerts parents when their baby's heart rate or blood oxygen saturation falls out of a prescribed range.
Video game-based therapeutic company Akili and baby tech company Owlet also post first quarter results.
CEO Kurt Workman said the company recently made two FDA submissions for baby health monitoring products.